SOFA Score Calculator — Sequential Organ Failure Assessment

About

The Sequential Organ Failure Assessment (SOFA) score was developed by the European Society of Intensive Care Medicine (ESICM) through a consensus conference in 1994, with the original description published by Vincent et al. in Intensive Care Medicine. The initial goal was to create an objective, reproducible tool to quantify the severity of organ dysfunction across six organ systems—respiratory, coagulation, liver, cardiovascular, neurological, and renal—in septic patients. Each system is scored from 0 (normal function) to 4 (most severe dysfunction), yielding a total score range of 0 to 24. The score was later validated in large, multicenter ICU populations encompassing over 40,000 patients across North America and Europe, demonstrating a strong and consistent correlation between increasing scores and in-hospital mortality. The SOFA score was formally incorporated into the Sepsis-3 definitions in 2016, where an acute increase of 2 points or more above baseline in the setting of infection became the operational definition of sepsis-related organ dysfunction. Today, SOFA is the most widely cited organ failure assessment tool in critical care research and is endorsed by the Surviving Sepsis Campaign, the Society of Critical Care Medicine (SCCM), and the European Society of Intensive Care Medicine for routine ICU monitoring and prognostication.

Formula

SOFA = Respiration (0-4) + Coagulation (0-4) + Liver (0-4) + Cardiovascular (0-4) + Neurological (0-4) + Renal (0-4)

The SOFA score is calculated by summing the points from six organ system assessments, each scored from 0 to 4. The respiratory component uses the PaO2/FiO2 ratio, with lower values indicating more severe gas exchange impairment; points increase when the ratio falls below 400, 300, 200 (with respiratory support), and 100 (with respiratory support). The coagulation component evaluates platelet count, where counts below 150, 100, 50, and 20 x10³/µL correspond to increasing points. The liver component is based on serum bilirubin levels, with thresholds at 1.2, 2.0, 6.0, and 12.0 mg/dL. The cardiovascular component assesses mean arterial pressure and vasopressor requirements: MAP below 70 mmHg scores 1 point, while escalating doses of dopamine, dobutamine, epinephrine, or norepinephrine score 2 to 4 points. The neurological component uses the Glasgow Coma Scale, with scores of 13-14 (1 point), 10-12 (2 points), 6-9 (3 points), and below 6 (4 points). The renal component uses serum creatinine and urine output, with thresholds at 1.2, 2.0, 3.5, and 5.0 mg/dL or urine output below 500 and 200 mL/day. The total score ranges from 0 to 24, and in general, the higher the total, the greater the degree of organ dysfunction across multiple systems. Serial measurements, commonly every 24 to 48 hours, allow clinicians to track the trajectory of organ failure and response to therapy.

Score Interpretation

The SOFA score is a cornerstone of modern critical care prognostication. The Surviving Sepsis Campaign (SSC) 2021 guidelines explicitly recommend using SOFA (or qSOFA in non-ICU settings) to identify patients with sepsis-related organ dysfunction. Specifically, an acute increase of 2 or more points in the SOFA score consequent to infection defines sepsis according to the Sepsis-3 consensus. Beyond diagnosis, serial SOFA assessments have demonstrated strong prognostic value: each one-point increase in SOFA over the first 48 hours is associated with approximately a 10-15% increase in mortality risk. Multiple large cohort studies have shown that the trend in SOFA—whether improving, stable, or worsening—is more informative than any single measurement. In clinical practice, SOFA scoring guides resource allocation, helps identify patients who may benefit from advanced organ support such as renal replacement therapy or ECMO, and is used as a stratification tool in clinical trials evaluating new sepsis therapies. The score is also incorporated into ICU performance benchmarking, where standardized mortality ratios adjusted for SOFA scores allow comparisons across institutions. Despite its widespread use, SOFA has limitations: it requires laboratory values that may not be immediately available, and it does not account for pre-existing organ dysfunction, which can confound baseline assessment. Nonetheless, SOFA remains the reference standard for organ failure quantification in critical care research and clinical practice.

Reference Ranges